ÍøºìºÚÁÏ

Skip to main content

Paul L Crispen, MD : Research

Cancer Specialist (Oncologist), Urologist

Photo of Paul L Crispen

Research at a glance

Top areas of exploration

  • Kidney Neoplasms , 39 publications
  • Carcinoma, Renal Cell , 28 publications
  • Nephrectomy , 20 publications
  • Prostatic Neoplasms , 16 publications

Research activity

95 publications

4,527 citations

Why is this important?

Active clinical trials

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

Bladder cancer is the 8th most common cancer in the ÍøºìºÚÁÏ Cancer Center catchment area and the 7th most common cancer presenting to UFÍøºìºÚÁÏ. Most newly diagnosed cases are stage I bladder cancer, which is defined by having no deep muscle…

Investigator
Paul L Crispen
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

95 publications

2019

Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.

Urology

•

2018

Evaluation of Intraoperative Versus Postoperative Adjuvant Mitomycin C with Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract.

Bladder cancer (Amsterdam, Netherlands)

•

2017

Delayed Intervention of Small Renal Masses on Active Surveillance.

Journal of kidney cancer and VHL

•

2017

Lymph Node Dissection for Small Renal Masses.

The Urologic clinics of North America

•

2016

Editorial Commentary.

Urology practice

•